A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples